共 37 条
- [31] Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., Cristofalo D., Aprili G., Tansella M., Dazzan P., DiForti M., Murray R.M., Collier D.A., Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients, American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 144, 5, pp. 647-659, (2007)
- [32] Toulopoulou T., Murray R.M., Verbal memory deficit in patients with schizophrenia: An important future target for treatment, Expert Review of Neurotherapeutics, 4, 1, pp. 43-52, (2004)
- [33] Wagner M., Shuhmacher A., Schwab S., Et al., The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans, Int. J. Neuropsychopharmacol., 9, pp. 1-5, (2008)
- [34] Warren J.T., Peacock M.L., Rodrigues L.C., Fink L.G., An Msp1 polymorphism in the human serotonin receptor gene (5HTR2A): Detection by DGGE and FLP analysis, Hum. Mol. Genet., 2, (1993)
- [35] Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., Herman M.M., Weinberger D.R., Kleinman J.E., Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain, Archives of General Psychiatry, 61, 6, pp. 544-555, (2004)
- [36] Williams J., Spurlock G., McGuffin P., Et al., Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group, Lancet, 347, (1996)
- [37] Whyte M.C., McIntosh A.M., Johnstone E.C., Lawrie S.M., Declarative memory in unaffected adult relatives of patients with schizophrenia: A systematic review and meta-analysis, Schizophr. Res., 78, pp. 13-26, (2005)